Sculptor Capital’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-767,528
Closed -$7.67M – 751
2022
Q4
$7.67M Hold
767,528
– – 0.13% 181
2022
Q3
$7.47M Hold
767,528
– – 0.09% 273
2022
Q2
$7.44M Buy
767,528
+3,900
+0.5% +$37.9K 0.08% 307
2022
Q1
$7.42M Buy
763,628
+476,127
+166% +$4.6M 0.06% 327
2021
Q4
$2.82M Buy
287,501
+227,461
+379% +$2.23M 0.02% 520
2021
Q3
$590K Buy
+60,040
New +$593K ﹤0.01% 631

Other funds holding DALS

Sculptor Capital's DALS Position: Q1 2023 in Review

Sculptor Capital sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q1 2023, closing a stake of 767,528 shares — an estimated $7.67M sold.

Sculptor Capital first reported a position in DALS in Q3 2021 and held it in 6 quarters. The position peaked at $7.67M in Q4 2022. 50 funds tracked by Wall St. Rank hold DALS as of Q1 2023.

  • Sculptor Capital reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q1 2023 after selling out during the quarter.
  • Sculptor Capital sold 767,528 DA32 Life Science Tech Acquisition Corp shares in Q1 2023, an estimated $7.67M.
  • Sculptor Capital first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 6 quarters.
  • Sculptor Capital's DA32 Life Science Tech Acquisition Corp position peaked at $7.67M in Q4 2022.
  • 50 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q1 2023.

Based on Sculptor Capital's 13F filing for Q1 2023, filed 16 May 2023.